Emily Q Pham, PA
Physician Assistant · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Emergency Physicians Associates San Jose PC · 131 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Emily Q Pham’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$888
Medicare paid this office $888 for 16 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
16 Original Medicare patients in 2024. Average age 60 · 85 and older 0% · Health risk score 3.15. Sicker patients than 9 in 10 peers; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75%.
The office billed $8,015, Medicare allowed $1,296 and paid $888; for 17 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 16 | 17 | 60 | 3.15 | $8,015 | $888 |
| 2021 | 284 | 1,873 | 74 | 1.42 | $219,906 | $76,154 |
| 2020 | 256 | 1,392 | 74 | 1.49 | $190,230 | $61,092 |
| 2019 | 31 | 184 | 77 | 1.38 | $40,475 | $10,737 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2021: 36 services
| Return visit (30+ min) | 232 | $30,097 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $7,435 | $75 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,531 | $137 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 11 | $2,952 | $67 |
| Transitional care management services for problem of high complexity | 11 | $2,747 | $211 |
| New patient visit (45+ min) | 11 | $1,414 | $129 |
| Parathormone (parathyroid hormone) level | 28 | $1,280 | $41 |
| Vitamin d-3 level | 34 | $1,184 | $30 |
| Blood test, thyroid stimulating hormone (tsh) | 41 | $773 | $17 |
| Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | 17 | $716 | $42 |
| Annual alcohol misuse screening, 5 to 15 minutes | 39 | $703 | $18 |
| Blood test, basic group of blood chemicals (calcium, total) | 66 | $677 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 62 | $591 | $8 |
| Thyroid hormone, t3 measurement, total | 36 | $567 | $14 |
| Blood test, lipids (cholesterol and triglycerides) | 35 | $562 | $13 |
| Cyanocobalamin (vitamin b-12) level | 28 | $528 | $15 |
| Liver function blood test panel | 50 | $507 | $8 |
| Ferritin (blood protein) level | 26 | $463 | $14 |
| C-peptide (protein) level | 18 | $437 | $21 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 27 | $435 | $14 |
| Folic acid level, serum | 25 | $426 | $15 |
| Thyroxine (thyroid chemical), free | 40 | $397 | $9 |
| Hemoglobin a1c level | 34 | $369 | $9 |
| Testosterone (hormone) level, total | 11 | $336 | $26 |
| Microsomal antibodies (autoantibody) measurement | 20 | $335 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 30 | $317 | $10 |
| Iron binding capacity | 26 | $297 | $9 |
| Insertion of needle into vein for collection of blood sample | 65 | $249 | $3 |
| Iron level | 26 | $220 | $6 |
| Magnesium level | 26 | $188 | $7 |
| Manual urinalysis test with examination using microscope, automated | 38 | $136 | $3 |
| Injection of drug or substance under skin or into muscle | 12 | $130 | $10 |
| Phosphate level | 24 | $128 | $5 |
| Creatine kinase (cardiac enzyme) level, total | 17 | $124 | $7 |
| Uric acid level, blood | 23 | $118 | $5 |
| Blood glucose (sugar) test performed by hand-held instrument | 13 | $52 | $3 |
2020: 34 services
| Return visit (30+ min) | 206 | $22,761 | $76 |
| Critical care, first 30-74 minutes | 11 | $6,760 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $4,515 | $77 |
| Telephone medical discussion with physician, 21-30 minutes | 39 | $3,744 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,971 | $149 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 42 | $822 | $19 |
| Testing for presence of drug, by chemistry analyzers | 11 | $684 | $62 |
| Vitamin d-3 level | 22 | $650 | $30 |
| Parathormone (parathyroid hormone) level | 15 | $618 | $41 |
| Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | 12 | $590 | $42 |
| Blood test, basic group of blood chemicals (calcium, total) | 50 | $505 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 51 | $433 | $8 |
| Blood test, thyroid stimulating hormone (tsh) | 22 | $369 | $17 |
| Liver function blood test panel | 42 | $358 | $8 |
| Thyroid hormone, t3 measurement, total | 20 | $297 | $14 |
| C-peptide (protein) level | 14 | $291 | $21 |
| Testosterone (hormone) level, total | 11 | $283 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 21 | $273 | $13 |
| Ferritin (blood protein) level | 17 | $245 | $14 |
| Cyanocobalamin (vitamin b-12) level | 16 | $241 | $15 |
| Cortisol (hormone) measurement, total | 14 | $228 | $16 |
| Folic acid level, serum | 15 | $221 | $15 |
| Thyroxine (thyroid chemical), free | 23 | $216 | $9 |
| Hemoglobin a1c level | 21 | $203 | $10 |
| Insertion of needle into vein for collection of blood sample | 47 | $176 | $3 |
| Iron binding capacity | 17 | $157 | $9 |
| Injection of drug or substance under skin or into muscle | 11 | $130 | $9 |
| Manual urinalysis test with examination using microscope, automated | 33 | $126 | $3 |
| Iron level | 17 | $116 | $6 |
| Magnesium level | 16 | $107 | $7 |
| Creatine kinase (cardiac enzyme) level, total | 16 | $104 | $7 |
| Uric acid level, blood | 16 | $72 | $5 |
| Phosphate level | 15 | $71 | $5 |
| Blood glucose (sugar) test performed by hand-held instrument | 16 | $62 | $3 |
2019: 1 service
| Return visit (30+ min) | 15 | $1,229 | $68 |
Money from drug and device companies
$99 in 2025
| 2025 | 1 | 1 | None | $99 |
| 2024 | 1 | 1 | None | $18 |
| 2022 | 2 | 4 | None | $97 |
| 2021 | 24 | 138 | None | $3,042 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Intuitive Surgical | Da Vinci Surgical System | $99 | 1 payment
|
See the published payment
| Intuitive Surgical | Meals · 2025-12-09 | Da Vinci Surgical System | $99 |
See earlier years (2024, 2022, 2021)
2024: $18
| Tris Pharma | Dyanavel Xr | $18 | 1 payment
|
2022: $97
| Insulet | Omnipod | $75 | 3 payments
|
| Corcept Therapeutics | Korlym | $22 | 1 payment
|
2021: $3,042
| AbbVie | Ubrelvy | $630 | 33 payments
|
| Amgen | Aimovig | $415 | 16 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $361 | 9 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $271 | 13 payments
|
| Nestle HealthCare Nutrition | Zenpep | $219 | 6 payments
|
| Esperion Therapeutics | Nexlizet | $161 | 5 payments
|
| Novo Nordisk | Rybelsus | $143 | 8 payments
|
| Zealand Pharma US | V-Go Disposable Insulin Delivery | $129 | 6 payments
|
| Corcept Therapeutics | Korlym | $92 | 5 payments
|
| Insulet | Omnipod | $80 | 4 payments
|
| Amarin Pharma | Vascepa | $77 | 4 payments
|
| Dexcom | Dexcom G6 Transmitter | $74 | 4 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $61 | 3 payments
|
| Antares Pharma | Xyosted | $58 | 4 payments
|
| Otsuka America Pharmaceutical | Jynarque | $55 | 3 payments
|
| Alexion Pharmaceuticals | Strensiq | $38 | 2 payments
|
| Currax Pharmaceuticals | Contrave | $32 | 2 payments
|
| MannKind | Afrezza | $30 | 2 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $26 | 1 payment
|
| Daiichi Sankyo | Injectafer | $23 | 1 payment
|
| Eisai | Dayvigo | $20 | 1 payment
|
| Lilly USA | Humulin | $18 | 1 payment
|
| Xeris Pharmaceuticals | Gvoke Pfs | $17 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $15 | 1 payment
|
Professional record
- NPI
- 1730644527
- Trained
- University of Pittsburgh School of Medicine, 2018
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 26661 Sotelo, Mission Viejo, CA, 92692
- NPI first listed
- 2019-02-05
- NPI last updated
- 2019-10-31
This is when the NPI record was last certified, not a medical board exam.